No Data
Jefferies Maintains Biogen(BIIB.US) With Buy Rating, Maintains Target Price $250
Jefferies Remains a Buy on Biogen (BIIB)
S&P 500, Dow Hit Records Right After Open | Live Stock
Are Wall Street Analysts Predicting Biogen Stock Will Climb or Sink?
Trump Picks Surgeon Makary to Head FDA, Rep. Dave Weldon to Lead CDC
Weekly Buzz: Nvidia Falls on Near Perfect Report, but Only For a Day